The nosocomial pneumonia prevention market is expected to grow on a healthy note over the next decade. With the resumption of value-based care, nearly 15% of the total population is now under its umbrella. Programs such as “Online Bachelor of General Studies with Health Care Concentration” are being launched, which could help professionals lead value-based care strategies. In other words, the future belongs to professionals who bring conventional communication, caring, and leadership skills with advanced analytical and technological skills. So, “being value-based” would have value in the healthcare vertical in the future.
Get a sample copy of this report @ https://www.persistencemarketresearch.com/samples/22768
Over an assessment period of eight years 2018-2026, the global nosocomial pneumonia prevention market is expected to witness moderate growth, according to a recent research report on the global nosocomial pneumonia prevention market. The report was published by Persistence Market Research and is titled “Hospital-Associated Pneumonia Prevention Market: Global Industry Analysis 2013-2017 and Forecast 2018-2026”. The US$795 million market is expected to grow at a CAGR of 4.7%, reaching a value of over US$1,100 million by the end of 2026.
Sage Products LLC (Stryker Corporation)
Medline Industries, Inc.
Halyard Health, Inc.
Methodology [email protected] https://www.persistencemarketresearch.com/methodology/22768
Key Market Drivers: Overview
Immunosenescence will remain a key driver of demand for nosocomial pneumonia prevention worldwide. The expansion of the geriatric population and consequent cessation of immunity is expected to maintain the need to regulate hospital-acquired pneumonia infection. Rising cases of chronic diseases leading to progressive weakening of the immune system also marks another strong driver for market growth over the next few years. The cessation of immunity in turn prolongs patients’ stay in hospitals, making them more susceptible to infections such as pneumonia. The global nosocomial pneumonia prevention market is expected to benefit from a continued surge of such cases, including people of all age groups.
Amplification of patient pool across the globe coupled with increasing number of hospitals in both developed and developing economies is expected to drive up the market scenario in the near future. Additionally, several countries are mandating the implementation of pneumonia prevention protocols, which is apprehended to create multiple growth opportunities in the coming years. The market growth in developing economies will be specifically accelerated by the soaring burden of pneumonia cases in Southeast Asian countries. The medical tourism industry is thriving in emerging countries such as India is expected to fuel nosocomial pneumonia cases and hence increase the demand for its prevention in the coming years.
Access the full [email protected] https://www.persistencemarketresearch.com/checkout/22768
By Product Type, the market has been segmented into:
Oral Care Kit
By end-user, the market is classified as:
Home care settings
Regional Analysis: Overview
The regional segmentation of Global Nosocomial Pneumonia Prevention categorizes the market into North America, Latin America, Europe, Asia-Pacific excluding China, China, Middle East & Africa. Among these, North America will remain dominant in all other regional markets, mainly due to a favorable initiative by the US government to encourage innovation in the field of antibacterial drugs. This government activity aims to respond to the urgent demand for better preventive measures against bacterial infections. Moreover, the demand for high quality oral care products in intensive care departments of hospitals has increased due to the increase in cases of chronic kidney disease since the recent past. Europe occupies the second position in terms of market size, APEC is expected to be the third largest lucrative region; while China is expected to be the most promising emerging market with the highest estimated CAGR value of around 5.5%.
Full report [email protected] https://www.persistencemarketresearch.com/market-research/hospital-acquired-pneumonia-prevention-market.asp
Key Market Players: Overview
Key companies operating in the global nosocomial pneumonia prevention market include Halyard Health, Inc., Sage Products LLC, Intersurgical Ltd., Medline Industries, Inc. and others. Attributed to the strong presence of a majority of key players such as Halyard Health, Inc., Medline Industries, Inc. and Stryker Corporation (SAGE Products LLC) in the United States, it has played a crucial role in improving the performance of the North American market for products acquired in the hospital setting. prevention of pneumonia over the years. As the number of specialized companies in the industry is limited, the overall scenario will remain price sensitive over the next few years.
IV Equipment Market – https://www.persistencemarketresearch.com/market-research/iv-equipment-market.asp
Gamma Knife Market – https://www.persistencemarketresearch.com/market-research/gamma-knife-market.asp
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York, NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com
Persistence Market Research is here to provide businesses with a one stop solution when it comes to improving customer experience. It is committed to gathering appropriate feedback after going through personalized customer interactions to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. The best possible yields are guaranteed.
This press release was published on openPR.